MTEX

FLOWER MOUND, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (Nasdaq: MTEX) (the "Company"), a global health and wellness company committed to transforming lives to make a better world, announced that its shareholders passed all proposals put to a vote at the Company’s annual shareholder meeting (the "Meeting") held Tuesday, June 2, 2026. Mannatech’s Chairman of the Board, J. Stanley Fredrick, chaired the Meeting and Yasir Haider, Interim Chief Financial Officer, reported to the shareholders on the Company’s 2025 financial results. At the close of business on April 6, 2026, the record date for determining shareholders entitled to vote at the Meeting, there were 1,929,670 shares of the Company’s common stock, par value $0.0001 per share, outstanding (the “Shares”). Proxies representing 1,369,880 Shares were received, validated, and voted at the Meeting, constituting 71.0% of the Shares entitle to vote. The following matters were submitted and voted upon at the Meeting. 1. Mannatech shareholders voted on the election of two individuals to the Board of Directors as Class III Directors to hold office until 2029 as set forth below: 2. Mannatech shareholders voted to ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ended December 31, 2026, as set forth below: 3. Mannatech shareholders approved, on an advisory basis, the compensation of Mannatech’s named executive officers as set forth below: About Mannatech Mannatech, Incorporated, is committed to transforming lives through the development, marketing, and sales of high-quality, proprietary nutritional supplements, topical and skin care and anti-aging products, and weight-management products distributed through its global network of independent associates and members. The company has been operating for more than 25 years of experience with operations in 25 markets^. For more information, visit Mannatech.com. ^Mannatech operates in China under a cross-border e-commerce platform that is separate from its network marketing model. Please Note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be...

FLOWER MOUND, Texas, May 14, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its first quarter of 2026. First Quarter Results Management's Statement Changes in current trade policies, including with respect to tariffs, could affect our cost structure and profitability. While we take steps to mitigate or avoid these increased costs and disruptions, our ability to do so may be limited by operational and supply chain constraints and uncertainties, especially in the short term. Non-GAAP Financial Measures In addition to results presented in accordance with GAAP, this press release and related tables include certain non-GAAP financial measures, including a presentation of Constant dollar measures. The company discloses operating results that have been adjusted to exclude the impact of changes due to the translation of foreign currencies into U.S. dollars, including changes in: Net Sales, Gross Profit, and Loss from Operations. The Company believes that these non-GAAP financial measures provide useful information to investors because they are an indicator of the strength and performance of ongoing business operations. The constant currency figures are financial measures used by management to provide investors with an additional perspective on trends. Although management believes the non-GAAP financial measures enhance investors’ understanding of their business and performance, these non-GAAP financial measures should not be considered an exclusive alternative to accompanying GAAP financial measures. Please see the accompanying table entitled "Non-GAAP Financial Measures" for a reconciliation of these non-GAAP financial measures. Safe Harbor statement This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “may,” “will,” “should,” "hope," “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “approximates,” “predicts,” “projects,” “potential,” and “continues” or other s...

FLOWER MOUND, Texas, April 17, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its fourth quarter and year ended 2025. Fourth Quarter Results Fourth quarter net sales for 2025 were $26.6 million, a decrease of $2.4 million, or 8.2%, as compared to $29.0 million in the fourth quarter of 2024. During the fourth quarter, the Company's net sales declined 7.6% on a Constant dollar basis (a Non-GAAP financial measure); unfavorable foreign exchange during the fourth quarter caused a decrease of $0.2 million in net sales as compared to the fourth quarter of 2024. Gross profit as a percentage of net sales decreased to 75.3% for the three months ended December 31, 2025, as compared to 80.5% for the same period in 2024. For the three months ended December 31, 2025, overall selling and administrative expenses decreased by $0.6 million to $9.8 million, as compared to $10.4 million for the same period in 2024. The decrease in selling and administrative expenses consisted primarily of a $0.2 million decrease in legal and consulting fees, a $0.1 million decrease in travel and entertainment costs, a $0.1 million decrease in bad debt, a $0.1 million decrease in miscellaneous administrative expenses and a $0.1 million decrease in warehouse costs. Fourth quarter operating loss for 2025 was $0.2 million as compared to operating income of $0.9 million for the fourth quarter of 2024. Fourth quarter net loss was $11.3 million, or $5.94 per diluted share, for the fourth quarter 2025, as compared to net income of $2.3 million, or $1.20 per diluted share, for the fourth quarter 2024. The higher net income in 2024 was a result of foreign currency exchange gains. Year End Results Net sales for 2025 were $108.0 million, a decrease of $9.9 million, or 8.3%, as compared to $117.9 million in 2024. Foreign currency exchange rate fluctuations had an overall unfavorable impact on 2025 net sales, reducing revenue by approximately $1.9 million compared to the prior year. On a Constant dollar basis (a Non-GAAP financial measure), net sales declined 6.8% in 2025 as compared to 2024. A significant portion of the revenue decline-approximately 15% of the total decrease in North America-was attributable to the implementation of a...

FLOWER MOUND, Texas, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2025. Third Quarter Results Net sales for the quarter ended September 30, 2025 were $29.2 million, as compared to $31.7 million for the same period in 2024, a decrease of $2.6 million, or 8.1%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $2.3 million, or 7.3%, and unfavorable foreign exchange caused a $0.2 million decrease in GAAP net sales as compared to the same period in 2024. The decline in revenues was principally due to slowing demand in certain regions we operate within, however sales for the third quarter of 2025 were higher than the first two quarters of 2025. Gross profit as a percentage of net sales increased to 76.4% for the three months ended September 30, 2025, as compared to 74.5% for the same period in 2024. The increase in gross profit as a percentage of net sales was primarily due to higher sales prices which was added in the third quarter of 2025 and lower inventory reserve additions compared to the same period in 2024. The timing of certain sales promotions also increased gross profit as a percentage of net sales during the quarter, compared to the same period in 2024. Commission expenses for the three months ended September 30, 2025 decreased by 10.7%, or $1.3 million, to $10.9 million, as compared to $12.2 million for the same period in 2024. Commissions are earned from sales. Commission expenses in dollar terms decreased during the three months ended September 30, 2025 primarily due to a decline in our sales. For the three months ended September 30, 2025, commissions as a percentage of net sales decreased to 37.5% from 38.3% for the same period in 2024. For the three months ended September 30, 2025, selling and administrative expenses decreased by $0.7 million, or 7.8%, to $9.1 million, as compared to $9.8 million for the same period in 2024. The decrease in selling and administrative expenses was the result of a $0.4 million reduction in payroll costs, a $0.1 million decrease in travel and entertainment costs, a $0.1 million decrease in warehouse costs and a $0.1 million decrease in charitable contributions. Selling and administr...

FLOWER MOUND, Texas, August 12, 2025--(BUSINESS WIRE)--Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2025. Second Quarter Results Net sales for the quarter ended June 30, 2025 were $25.7 million, as compared to $27.7 million for the same period in 2024, a decrease of $2.1 million, or 7.4%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $1.8 million, or 6.5%, and unfavorable foreign exchange caused a $0.2 million decrease in GAAP net sales as compared to the same period in 2024. The decline in revenues was principally due to slowing demand in certain regions we operate within due to weakened economic conditions, relative to the prior year. Gross profit as a percentage of net sales decreased to 73.6% for the three months ended June 30, 2025, as compared to 77.1% for the same period in 2024, some of the increase in costs were related to increased freight costs related to back ordered items and running sales promotions on products thereby reducing our gross profit margin. Commission expenses for the three months ended June 30, 2025 decreased by 14.4%, or $1.6 million, to $9.5 million, as compared to $11.1 million for the same period in 2024. Commissions are earned from sales. Commission expenses in dollar terms decreased during the three months ended June 30, 2025 primarily due to a decline in our sales. For the three months ended June 30, 2025, commissions as a percentage of net sales decreased to 37.0% from 40.0% for the same period in 2024. For the three months ended June 30, 2025, selling and administrative expenses decreased by $0.1 million, or 0.8%, to $10.8 million, as compared to $10.9 million for the same period in 2024. The decrease in selling and administrative expenses was the result of a $0.4 million reduction in payroll costs, which was offset by a $0.2 million increase in marketing costs and a $0.1 million increase in office expenses. Selling and administrative expenses, as a percentage of net sales, for the three months ended June 30, 2025 increased to 42.0% from 39.1% for the same period in 2024. Loss from operations was $1.4 million for the three months ended June 30, 2025 as compared to $1.1 million in the same period last year. Income tax...

FLOWER MOUND, Texas, June 05, 2025--(BUSINESS WIRE)--Mannatech, Incorporated (Nasdaq: MTEX) ("Mannatech"), a global health and wellness company committed to transforming lives to make a better world, announced that its shareholders passed all proposals put to a vote at Mannatech’s annual shareholder meeting (the "Meeting") held Tuesday, June 3, 2025. Mannatech’s Chairman of the Board, J. Stanley Fredrick, chaired the Meeting, and James Clavijo, Mannatech’s Chief Financial Officer, spoke to the shareholders sharing the company’s financial results for 2024. There were 1,900,930 outstanding shares of Mannatech’s common stock as of April 8, 2025 entitled to vote and 1,478,342 shares, or approximately 77.8% represented at the Meeting, either in person or by proxy. The following matters were submitted and voted upon at the Meeting: 1. Mannatech shareholders voted on the election of two individuals to the Board of Directors as Class II Directors to hold office until 2028 as set forth below: 2. Mannatech shareholders voted to ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ended December 31, 2025 as set forth below: 3. Mannatech shareholders approved, on an advisory basis, the compensation of Mannatech’s named executive officers as set forth below: 4. Mannatech shareholders approved, on an advisory basis, the frequency of future votes on compensation of Mannatech’s named executive officers as set forth below: To begin improving your life and the lives of those around you, please visit Mannatech.com. About Mannatech Mannatech, Incorporated, is committed to transforming lives through the development, marketing, and sales of high-quality, proprietary nutritional supplements, topical and skin care and anti-aging products, and weight-management products distributed through its global network of independent associates and members. The company has been operating for more than 25 years of experience with operations in 25 markets^. For more information, visit Mannatech.com. ^Mannatech operates in China under a cross-border e-commerce platform that is separate from its network marketing model. Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private S...

FLOWER MOUND, Texas, May 13, 2025--(BUSINESS WIRE)--Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its first quarter of 2025. First Quarter Highlights Net sales for the quarter ended March 31, 2025 were $26.6 million, as compared to $29.4 million for the same period in 2024, a decrease of $2.8 million, or 9.6%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $1.6 million, or 5.4%, and unfavorable foreign exchange caused a $1.2 million decrease in GAAP net sales as compared to the same period in 2024. The decline in revenues was principally due to slowing demand in Asia due to weakened economic conditions, relative to the prior year. Gross profit as a percentage of net sales decreased to 74.3% for the three months ended March 31, 2025, as compared to 78.6% for the same period in 2024, some of the increase in costs were related to increased freight costs related to back ordered items and running sales promotions on products thereby reducing our gross profit margin. Commission expenses for the three months ended March 31, 2025 decreased by 10.5%, or $1.2 million, to $10.0 million, as compared to $11.2 million for the same period in 2024. Commissions are earned from sales. Commission expenses in dollar terms decreased during the three months ended March 31, 2025 primarily due to a decline in our sales. For the three months ended March 31, 2025, commissions as a percentage of net sales decreased to 37.7% from 38.1% for the same period in 2024. For the three months ended March 31, 2025, selling and administrative expenses decreased by $0.6 million, or 5.4%, to $10.0 million, as compared to $10.6 million for the same period in 2024. The decrease in selling and administrative expenses was the result of a $0.8 million reduction in payroll costs, which was offset by a $0.2 million increase in legal and consulting fees. Selling and administrative expenses, as a percentage of net sales, for the three months ended March 31, 2025 increased to 37.7% from 36.0% for the same period in 2024. Loss from operations was $0.8 million for the three months ended March 31, 2025 as compared to income from operations of $0.8 million in the same period last year. Income tax expense was $0.2 million for the...

FLOWER MOUND, Texas, March 26, 2025--(BUSINESS WIRE)--Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its fourth quarter of 2024. Quarter End Results Fourth quarter net sales for 2024 were $29.0 million, a decrease of $3.7 million, or 11.3%, as compared to $32.7 million in the fourth quarter of 2023. During the fourth quarter, the company's net sales declined 9.2% on a Constant dollar basis (a Non-GAAP financial measure); unfavorable foreign exchange during the fourth quarter caused a decrease of $0.7 million in net sales as compared to the fourth quarter of 2023. Gross profit as a percentage of net sales improved to 80.5% for the three months ended December 31, 2024, as compared to 75.4% for the same period in 2023. Commissions as a percentage of net sales were 40.6% for the three months ended December 31, 2024, as compared to 39.6% for the same period in the prior year. Incentive costs as a percentage of net sales were 1.0% for the three months ended December 31, 2024, as compared to 1.4% for the same period in 2023. For the three months ended December 31, 2024, overall selling and administrative expenses decreased by $1.7 million to $10.4 million, as compared to $12.1 million for the same period in 2023. The decrease in selling and administrative expenses consisted primarily of a $0.9 million decrease in payroll related costs, a $0.7 million decrease in marketing costs and a $0.1 million decrease in travel and entertainment costs. Fourth quarter operating income for 2024 was $0.9 million as compared to an operating loss of $0.9 million for the fourth quarter of 2023. Fourth quarter net income was $2.3 million, or $1.20 per diluted share, for the fourth quarter 2024, as compared to a net loss of $1.8 million, or $0.94 per diluted share, for the fourth quarter 2023. The approximate number of new and continuing independent associate and preferred customer positions held by individuals in Mannatech’s network and associated with purchases of its packs or products as of December 31, 2024 and 2023 was approximately 133,000 and 145,000, respectively. Recruiting decreased 19.5% in the fourth quarter of 2024 as compared to the fourth quarter of 2023. The number of new independent associate and preferred customer positions in the company’s netwo...